{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-002034","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2023-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.086729+00:00","generated_at":"2026-06-20T12:24:45.361385+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Qualigen Therapeutics reduces executive salaries by 20%, terminates COO Shishir Sinha and CSO Wajdi Abdul-Ahad","bullets":["Board approved 20% temporary base salary reduction for all executive officers, including CEO, CFO, President, COO, and CMO, effective immediately.","COO Shishir Sinha terminated effective Feb 16, 2023; President Amy Broidrick's title becomes President, Chief Strategy and Operating Officer.","Non-executive director annual cash compensation reduced by 20%.","VP and Chief Scientific Officer Wajdi Abdul-Ahad position eliminated, along with several other non-executive roles."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-002034","json":"https://secwatch.observer/filing/0001493152-23-002034.json","markdown":"https://secwatch.observer/filing/0001493152-23-002034.md","text":"https://secwatch.observer/filing/0001493152-23-002034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:24:45.361385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e5404bf1d","claim":"Shishir Sinha was terminated as Chief Operating Officer and Senior Vice President, Diagnostics at AIxCrypto Holdings, Inc..","evidence_excerpt":"the Company provided notice to Mr. Sinha that his employment with the Company would be terminated effective February 16, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Operating Officer and Senior Vice President, Diagnostics"}],"fact_type":"executive_change"},{"claim_id":"9ce78310ea","claim":"Amy Broidrick changed role as President, Chief Strategy and Operating Officer at AIxCrypto Holdings, Inc..","evidence_excerpt":"Ms. Broidrick’s title will become President, Chief Strategy and Operating Officer, effective as of the Effective Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315223002034/0001493152-23-002034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"title will become"},{"label":"Role","value":"President, Chief Strategy and Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}